American Society of Hematology, Blood Advances, 7(4), p. 1192-1196, 2020
DOI: 10.1182/bloodadvances.2019001127
Full text: Download
Key Points The K666N mutation of SF3B1 has distinct clinicopathologic features in MDS. The K666N mutation of SF3B1 has a distinct RNA splicing profile.